Dr. Erin P. Gibbons, MD

Dr. Gibbons practices at Salmon Creek 1 Clinic in Vancouver, Washington.

Dr. Gibbons' NPI, 1063647816, was assigned on May 22, 2009. Dr. Gibbons graduated from University of Maryland School of Medicine - Baltimore in 2002. Dr. Gibbons holds Washington license MD60082232.

Dr. Gibbons' primary practice is Salmon Creek 1 Clinic, at 2525 Ne 139th Street, Vancouver, WA 98686. The practice phone is (360) 882-2778.

Dr. Gibbons' primary practice is Salmon Creek 1 Clinic in Vancouver, Washington. Dr. Gibbons is also affiliated with Legacy Salmon Creek Medical Center. The medical group on file is Vancouver Clinic. Dmand AI also links Dr. Gibbons to 1 more group practice or clinic, named with a free account. Dr. Gibbons' employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gibbons practices, 3 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gibbons' primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gibbons is board certified in urology by the American Board of Urology. Dmand AI has Dr. Gibbons' licenses on file in 2 states: Washington and Pennsylvania.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Gibbons treats.

CMS data shows 1,081 Medicare services from Dr. Gibbons across 24 procedure codes in 2024, for 284 Medicare patients. Medicare paid $53,818 for them.

CMS counts 284 Medicare patients who saw Dr. Gibbons in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gibbons' median patient age at 71, with 42% women.

In 2024, Dr. Gibbons wrote 1,418 Medicare Part D claims for 320 patients. 90% of them were for generic drugs. CMS names the drug for 1,293 of them, across 28 drugs with 11 or more claims each, at $106,164 in total drug cost. In 2023, CMS named 1,177 claims across 24 drugs.

Dr. Gibbons accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Gibbons as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Gibbons, published from 2008 to 2018. 2008 was the busiest year, with 3. The most frequent topics are Brachytherapy, Prostatic Neoplasms and Carcinoma, Renal Cell. Dr. Gibbons has published most often in Brachytherapy. Dr. Gibbons' most frequent co-authors are Sushil Beriwal, MD, Anthony Thomas Corcoran, MD and Benjamin J. Davies.

CMS Open Payments shows 12 general payments to Dr. Gibbons from 5 drug and device companies from 2019 to 2025. Travel and lodging make up the largest share, 59% of the total. NeoTract Inc. paid the most, $1,021.

Dmand AI lists 1 award for Dr. Gibbons, most recently CMS Stage 1 2012 in 2012.

Dr. Gibbons graduated from University of Maryland School of Medicine - Baltimore in 2002.

Dr. Gibbons is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.